Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Plain-language summary

This is a multicenter registry that collects information on patients with malignant peripheral nerve sheath tumors (MPNST). It is open to any patient diagnosed with MPNST who provides consent. It is being conducted as a registry study with no assigned phase and is still enrolling participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Washington University School of Medicine

Start date

4/28/2017

Estimated completion

4/30/2053

Countries

United States, Canada, India, Japan, United Kingdom

Related genes

Locations

• Tampa, United States
• Baltimore, United States
• Bethesda, United States
• Boston, United States
• Minneapolis, United States
• St Louis, United States
• New York, United States
• Providence, United States
• Salt Lake City, United States
• Toronto, Canada
• Mumbai, India
• Nagoya, Japan
• London, United Kingdom

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria and Exclusion Criteria:

-Any patient diagnosed with an MPNST is eligible for enrollment to this registry provided s/he consents to participate (or consent form his/her parent or legal guardian or legally authorized representative is obtained).